Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of esketamine on retroocular hemodynamics and intracranial pressure
ChiCTR2200057756Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Yangzhou University
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine (2 arms), sponsored by The Affiliated Hospital of Yangzhou University. Primary endpoints: Rate of blood flow in the posterior artery of the eyeball and Diameter of the optic nerve sheath. Started Mar 2022; status: recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2200057756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057756.